• Nausea & Vomiting
    Suppositories, troches, suspensions, topical transdermal gels

  • Excess Salivation
    Atropine Oral solution, Scopolamine topical gel

  • Pain
    Transdermal gels, suppositories, sustained-release capsules, troches, injectables, oral solution

  • Neuropathic Pain
    Transdermal gels to avoid GI side effects or incapable of swallowing

  • Dyspnea
    Inhalations

  • Seizures
    Suppositories, rectal gel, transdermal gels

  • Dry Mouth
    Saliva substitute gels and liquids, saliva stimulant troches, sprays, capsules

  • Thrush
    Troches, oral rinses, topical bases

  • Wound care with or without Decubitus Ulcers
    Cream / gel

Compounding

for Hospice

Examples of Compounding Medications for Hospice Care

Decubitus Ulcer Cream or Wound Care Combination

​

This compounded prescription medication contains Misoprostol for coating and Phenyltoin, an anti-ulcerative agent, for proliferation of new cells, and Lidocaine, a local anesthetic, for pain.

​

Diabetic Skin Ulcer Cream


This compounded prescription product contains Misoprostol and Phenytoin, both of which have been used in the treatment of skin ulcers, and Ketoprofen and Lidocaine, both topical analgesics in a cream base.

This compounding product is for external use only.

​

ABH Topical Gel/Suppositories/Capsules


This compounded prescription medication contains Lorazepam, Diphenhydramine and Haloperidol and can be used for hospice patients or patients receiving chemotherapy who are experiencing severe nausea, vomiting, and restlessness.

​

Gabapentin /  Ketoprofen /  Lidocaine  in a Transdermal Gel


This compounded prescription medication contains Gabapentin, an antiepileptic agent that has been shown to have analgesic properties, Ketoprofen, a non-steroidal anti-inflammatory agent, and Lidocaine, a local anesthetic.

​

This compounding product is used for topical application and may be helpful in the management of pain associated with diabetic peripheral neuropathy.

​

Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metroclopramide HCl 2.4% in a Transdermal Base

​

This compounded prescription medication is used to treat severe nausea, vomiting, and restlessness . It is a modification of the "ABHR" combination.

​

The medication is compounded in a transdermal base that allows for the ready absorption of the active ingredients through the skin.